For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Scientific Program

FP223

4477MW

Dr.Chandan Raghavendra Bhat
Membership No Author Name Email Mobile
4477MW Dr.Chandan Raghavendra Bhat chandan.bhat87@gmail.com 9538358926
Uvea

Posterior Sub-Tenon's Interferon Alfa-2b for Inflammatory Macular Edema: Single vs Serial Injections

Purpose: To evaluate anatomical and visual outcomes of single and serial posterior sub-Tenon's interferon alfa-2b (PSII) in inflammatory macular edema (IME).
Methods: Retrospective case series of IME treated with PSII. OCT measured central macular thickness (CMT). Recurrence was defined as relapse within 3 months or <50 µm CMT reduction at 1 month.
Results: Twenty-seven eyes (mean age 47.9 years) received single PSII. Mean CMT decreased from 614.6 to 433.6 µm at 1 week and was 505.5 µm at 1 month. BCVA improved from 20/63 to 20/40. Seven eyes (mean age 48.0 years) receiving serial PSII showed CMT reduction from 524.2 to 480.2 µm after the third injection, with BCVA improving from 20/60 to 20/40. One eye developed granulomatous uveitis and one mild papillary conjunctivitis.
Conclusions: PSII produced rapid anatomical and visual improvement in IME in the first week after single injection. Serial injections appeared to provide sustained anatomical improvement with favourable safety.

Membership No Author Name Email Mobile
1662N Dr.Ankush Ashok Kawali akawali332@gmail.com 9632368641